HILLSDALE INVESTMENT MANAGEMENT INC. – Intra-Cellular Therapies, Inc. Transaction History
HILLSDALE INVESTMENT MANAGEMENT INC. portfolio value:
$4.37M
portfolio value
HILLSDALE INVESTMENT MANAGEMENT INC. quarter portfolio value change:
-18.48%
quarter
Intra-Cellular Therapies, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +566.67% | 79.9K shares | 3.56M | $46.53 | 94K |
Q2 2022 | share | Increase | 0.00% | 14.1K shares | 805K | $57.08 | 14.1K |